Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Pr Paul Friedemann

In this page

Member info

Pr Paul Friedemann

Representative

Germany

Working Group(s): Neuro-Ophthalmology Rare Diseases (WG2), Registries & Epidemiology (TWG7), Research (TWG8)

Team

Dr Judith Bellmann-Strobl

Germany

See more

Dr Frederike Oertel

Germany

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

HCP Center

In addition to its role in research and teaching, the Hospital's fundamental mission also includes the care and treatment of patients. With 655.138...

contact

Charité – Universitätsmedizin Berlin, Germany

Charitépl. 1
10117 Berlin
Germany

Clinical trials

NCT05566795 Recruiting, Active

A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy

Interventional
See the trial
voir la fiche

NCT05063162 Recruiting, Active

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)

Interventional
See the trial
voir la fiche
NCT05271409 Recruiting, Active

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab As Monotherapy Or In Addition To Baseline Therapy In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Interventional
See the trial
voir la fiche
NCT05987423 Recruiting, Active

A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Moderate-To-Severe Thyroid Eye Disease

Interventional
See the trial
voir la fiche
NCT05811351 Recruiting, Active

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Interventional
See the trial
voir la fiche
NCT04270747 Completed

A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT05384249 Recruiting, Active

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Interventional
See the trial
voir la fiche
DRKS00023562 Recruiting, Active

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

Interventional
See the trial
voir la fiche

Scientific publications

Diagnosis and classification of optic neuritis

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not...

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

The largest and most robust differences between the eyes of people with multiple sclerosis and control eyes were found in the peripapillary RNFL...